Valentina Medici

Has grant

Professor

University of California, Davis
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Study of UX701 Gene Transfer for the Treatment of Wilson Disease

Open Date: 2023-03-01

Close Date: 2030-03-01

Grant: Close

NRSA Training Core (TL1)

Open Date: 2016-07-01

Close Date: 2026-05-31

Grant: Close

Epigenetic regulation of Wilson Disease

Open Date: 2016-04-01

Close Date: 2022-03-31

Grant: Close

Wilson Disease: Effect of High-Choline Feeding on Fetal and Offspring Mouse Liver

Open Date: 2014-07-01

Close Date: 2016-12-31

Grant: Close

Wilson Disease: Regulation of Steatosis by Methionine Metabolism

Open Date: 2010-06-01

Close Date: 2015-08-31

Articles (20)

Year:

2026

Year:

2026

Neuroimaging of blood-brain barrier permeability has been instrumental in identifying its broad involvement in neurological and systemic diseases. However, current methods evaluate the blood-brain barrier mainly as a structural barrier. Here we developed a non-invasive positron emission tomography method in humans to measure the blood-brain barrier permeability of molecular radiotracers that cross the blood-brain barrier through its molecule-specific transport mechanism. Our method uses high-temporal resolution dynamic imaging and kinetic modeling for multiparametric imaging and quantification of the blood-brain barrier permeability-surface area product of molecular radiotracers. We show, in humans, our method can resolve blood-brain barrier permeability across three radiotracers and demonstrate its utility in studying brain aging and brain-body interactions in metabolic dysfunction-associated steatotic liver inflammation. Our method opens new directions to effectively study the molecular permeability of the human blood-brain barrier in vivo using the large catalogue of available molecular positron emission tomography tracers.

Year:

2025

Objectives: Food insecurity among college students, combined with limited nutrition knowledge and barriers to healthy eating, significantly impacts diet quality and fruit and vegetable intake. Efforts to address these issues are further complicated by the challenges of accurately and efficiently collecting dietary data in research settings. This study aimed to explore the relationship between nutrition knowledge and fruit/vegetable intake using skin, plasma, and dietary carotenoid levels as biomarkers. Methods: Undergraduate and graduate students aged 18 years and older (n = 166) from a California public university were recruited. The sample was predominately female (n = 133, 80%), with 30 males (18%) and three individuals (2%) identifying as non-binary. Food security was assessed using the USDA’s 10-item Adult Food Security Survey Module and nutrition knowledge through a validated questionnaire. Biological data included blood samples and skin carotenoid measurements (Veggie Meter®). Dietary quality (HEI-2015) and carotenoid intake were assessed through Diet ID™, a photo-based assessment tool. Results: The mean nutrition knowledge scores were 36.55 ± 8.83 out of 58 points, and the mean skin carotenoid score was 307.07 ± 110.22. Higher knowledge scores were associated with increased plasma carotenoids, HEI-score, and Diet ID™ total carotenoids. Food security classification did not significantly impact nutrition knowledge but did influence HEI scores and skin carotenoid levels, with very low food security linked to poorer diet quality and lower carotenoid levels. Conclusions: Nutrition knowledge may serve as a significant predictor of fruit and vegetable intake in university students. Despite this correlation, the impact of overall diet quality is potentially hindered by an individual’s food security status. Therefore, while knowledge is critical, addressing food insecurity is essential for enhancing diet quality among college students.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background The objective was to develop consensus on minimal screening criteria for Wilson disease (WD) diagnosis in US gastroenterology and neurology settings for implementation in clinical practice to support the timely diagnosis of WD. Methods A modified Delphi panel with three rounds was conducted. The first round survey was developed with input from a steering committee of four clinical experts in WD who set the analysis rules (consensus: ≥ 80%). Other US gastroenterologists/hepatologists or neurologists with experience treating WD were recruited using purposive sampling, and 32 were invited to participate. Results Eleven panelists completed the three rounds. Consensus was reached for 94/126 (74.6%) statements. All panelists agreed that hepatomegaly, splenomegaly, or stigmata of liver disease are suggestive of WD in patients with a neuropsychiatric manifestation; a neurologic exam, 24‐h urine copper, ceruloplasmin, and Kayser–Fleischer (KF) ring examination should be performed; and liver biopsy and liver copper determination can be a useful final stage to confirm WD diagnosis. Panelists agreed that noninvasive testing should be performed prior to invasive testing and that the absence of KF rings does not exclude a diagnosis of WD. Panelists agreed that it is important to collaborate in a multidisciplinary team. Conclusions This study identified minimal criteria to raise suspicion of WD, minimal tests to confirm or rule out a WD diagnosis, and areas with poor consensus to be explored in future research. These results can complement clinical practice guidance and support cross‐specialty collaboration.

Year:

2025

Introduction: In recent years, there has been a growth in awareness of the importance of equity and community engagement in clinical and translational research. One key limitation of most training programs is that they focus on change at the individual level. While this is important, such an approach is not sufficient to address systemic inequities built into the norms of clinical and translational research. Therefore, it is necessary to provide training that addresses changing scientific norms and culture to ensure inclusivity and health equity in translational research. Method: We developed, implemented, and assessed a training course that addressed how research norms are based on histories and legacies of white supremacy, colonialism, and patriarchy, ultimately leading to unintentional exclusionary and biased practices in research. Additionally, the course provides resources for trainees to build skills in how to redress this issue and improve the quality and impact of clinical and translational research. In 2022 and 2023, the course was offered to cohorts of pre and postdoctoral scholars in clinical and translational research at a premier health research Institution. Results: The efficacy and immediate impact of three training modules, based on community engagement, racial diversity in clinical trials, and cancer clusters, were evaluated with data from both participant feedback and assessment from the authors. TL1 scholars indicated increased new knowledge in the field and described potential future actions to integrate community voices in their own research program. Conclusions: Results indicate that trainings offered new perspectives and knowledge to the scholars.

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (27)

Bettina Hieronimus

Max Rubner-Institut

GERMANY
View details

Alan Crozier

Fellow of the Distinguished Scientist Fellowship Program

king saud university

SAUDI ARABIA
View details

Anna Czlonkowska

Professor

Institute of Psychiatry and Neurology

POLAND
View details

Gunter Georg Christian Kuhnle

Professor of Nutrition and Food Science

University of Reading

UNITED KINGDOM
View details

Marie C. Heffern

Vice Chair of Academic Personnel

University of California

UNITED STATES
View details

Guobao Wang

Professor

university of california davis medical center

UNITED STATES
View details

Mikkel Holm Vendelbo

VIP, Associate Professor

Aarhus University

DENMARK
View details

Hong Li

Professor

University of California, Davis

UNITED STATES
View details

Yasser Abdelhafez

Specialist

University of California, Davis

UNITED STATES
View details

Lorenzo Nardo

Professor

UC Davis Health System

UNITED STATES
View details

Karen Matsukuma

University of California, Davis

UNITED STATES
View details

Hisham Hussan

Professor of Clinical Medicine

University of California, Davis

UNITED STATES
View details

Tagreed Mazi

Assistant Professor

king saud university

SAUDI ARABIA
View details

Marina Berenguer

Professor

University of Valencia

SPAIN
View details

Hans Zischka

Technical University of Munich

GERMANY
View details

Carmen Espinós

Professor

University of Valencia

SPAIN
View details

Ramsey Badawi

Professor

university of california davis medical center

UNITED STATES
View details

Thomas Damgaard Sandahl

VIP, Clinical Professor

Aarhus University

DENMARK
View details

Moon S Chen

Professor

UC Davis Health System

UNITED STATES
View details

Petr Dusek

-

CZECH REPUBLIC
View details

Simon R. Cherry

Prof. of Total-Body Imaging

University of California, Davis

UNITED STATES
View details

Victoria Lyo

Associate Professor of Surgery

University of California

UNITED STATES
View details

Rachel E. Scherr

San Francisco State University

UNITED STATES
View details

Souvik Sarkar

University of California

UNITED STATES
View details

Francene Steinberg

Vice Chair

University of California, Davis

UNITED STATES
View details

Suzanne Sharpton

Assistant Professor of Medicine

Vanderbilt University

UNITED STATES
View details

Deborah Fetter

Associate Professor of Teaching

University of California, Davis

UNITED STATES
View details